Stratus Medical is committed to ensuring digital accessibility for people with disabilities. We are continually improving the user experience for everyone and applying the relevant accessibility standards.
Our foundational technology, the NIMBUS® RF Multitined Expandable Electrode, was invented by an interventional pain physician seeking to overcome anatomical variability when targeting nerves. By creating a large-volume RF lesion, NIMBUS helps reduce uncertainty and supports more consistent, reproducible, and sustained pain relief. NIMBUS is easy to use, compatible with existing RF generators, and designed to help lower overall procedure costs for hospitals and ambulatory surgery centers.
NIMBUS has been validated in multiple independent clinical studies, with several prospective, Level I trials currently enrolling patients.
NIMBUS was FDA cleared in 2012, and CE Marked (including the Vesta® RF system), in 2021. Today, NIMBUS is available in six countries and is rapidly expanding.
Stratus Medical will continue to innovate and deliver new products to market, including an RF Generator (currently under development and not FDA cleared).
The Web Content Accessibility Guidelines (WCAG) defines requirements for designers and developers to improve accessibility for people with disabilities. It defines three levels of conformance: Level A, Level AA, and Level AAA.
Stratus Medical is making constant efforts to improve the accessibility of its site and services in the belief that it is our collective moral obligation to allow seamless, accessible, and unhindered use for those of us with disabilities.
We aim to make all pages and content on stratusmedical.com accessible, but some content may not yet fully meet the highest accessibility standards. This could be due to challenges in identifying the most suitable technological solution.
We may revise this Statement periodically to reflect improvements or changes to our accessibility practices.
English English 
Italiano
Português do Brasil
Português
Español
العربية
Background:
Radiofrequency neurotomy (RFN) can be an effective treatment for patients with chronic neck pain and cervicogenic headaches resistant to conservative care. However, the degree and duration of pain relief after RFN is dependent upon the thoroughness of target nerve coagulation.
Case Report:
This is a case of a 37-year-old patient with debilitating neck pain and headaches following a motor vehicle accident. Successful local anesthetic block of the third occipital nerve (TON) confirmed pain of C2-C3 facet joint origin. An initial RFN treatment of the TON, using standard 18G electrodes in bipolar mode, resulted in complete symptom amelioration for 8 months. Repeat RFN, using the same electrode configuration, was unsuccessful in alleviating the severe neck pain and headaches, and produced no demonstrable sensory loss in the distribution of the TON. RFN was then performed using the NIMBUS® electrosurgical RF multitined expandable electrode, which provides a larger zone of coagulation in volume than standard RFN electrodes even when used in bipolar configuration.
Conclusion:
The NIMBUS procedure resulted in successful coagulation of the TON with sensory loss in the TON distribution and reinstatement of palliative relief.
